Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Overview of attention for article published in Blood Cancer Journal, August 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#33 of 1,555)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 13 news outlets
blogs: 1 blog

twitter: 5 X users

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 15 news stories from 13 outlets.

Ligand Partner CASI Pharmaceuticals Launches EVOMELA® in China

Erie News Now, 12 Aug 2019

SAN DIEGO --(BUSINESS WIRE) Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner CASI Pharmaceuticals, Inc.

Ligand Partner CASI Pharmaceuticals Launches EVOMELA® in China

Equities.com, 12 Aug 2019

SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner CASI Pharmaceuticals, Inc.

Ligand Partner CASI Pharmaceuticals Launches EVOMELA® in China

Digital Journal, 12 Aug 2019

SAN DIEGO--(Business Wire)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner CASI Pharmaceuticals, Inc.

Ligand Partner CASI Pharmaceuticals Launches EVOMELA® in China

Bioportfolio, 12 Aug 2019

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner CASI Pharmaceuticals, Inc.

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 11 additional news stories.